ClinicalTrials.govpublic full text
Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)
squamous non-small cell lung cancer, squamous nsclc, nivolumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 841192
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.